APUS
AMEX · Biotechnology
Apimeds Pharmaceuticals Us I
$4.55
-0.15 (-3.19%)
Open$4.72
Previous Close$4.70
Day High$4.93
Day Low$4.55
52W High$403.10
52W Low$4.15
Volume—
Avg Volume50.8K
Market Cap7.09M
P/E Ratio—
EPS$-6.34
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 11.55M | 12.01M | 11.14M |
| Net Income | 858.8K | 710.2K | 724.1K |
| Profit Margin | 7.4% | 5.9% | 6.5% |
| EBITDA | 1.04M | 1.13M | 1.04M |
| Free Cash Flow | 935.0K | 714.0K | 1.10M |
| Rev Growth | -8.4% | +17.9% | -7.5% |
| Debt/Equity | 0.40 | 0.38 | 0.40 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |